We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNIT
2076
Uniti Group
UNIT
$2.28B
$4.24K ﹤0.01%
1,451
-2,286
-61% -$9.58K
FLS icon
2077
Flowserve
FLS
$10.2B
$4.23K ﹤0.01%
88
FR icon
2078
First Industrial Realty Trust
FR
$8.38B
$4.23K ﹤0.01%
89
-34
-28% -$1.63K
LPRO
2079
DELISTED
Open Lending Corp
LPRO
$4.22K ﹤0.01%
+756
New +$4.35K
SPCE icon
2080
Virgin Galactic
SPCE
$492M
$4.21K ﹤0.01%
500
-53
-10% -$961
RLAY icon
2081
Relay Therapeutics
RLAY
$4.39B
$4.21K ﹤0.01%
645
+304
+89% +$2.08K
APLS
2082
DELISTED
Apellis Pharmaceuticals
APLS
$4.18K ﹤0.01%
109
-195
-64% -$8.83K
PRGS icon
2083
Progress Software
PRGS
$1.76B
$4.18K ﹤0.01%
+77
New +$3.91K
CXW icon
2084
CoreCivic
CXW
$3.37B
$4.17K ﹤0.01%
321
+37
+13% +$540
MORF
2085
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4.16K ﹤0.01%
122
+30
+33% +$889
AIN icon
2086
Albany International
AIN
$1.77B
$4.14K ﹤0.01%
49
SKY icon
2087
Champion Homes
SKY
$5.14B
$4.13K ﹤0.01%
61
+26
+74% +$1.95K
EFSC icon
2088
Enterprise Financial Services Corp
EFSC
$2.4B
$4.13K ﹤0.01%
+101
New +$3.92K
KYN icon
2089
Kayne Anderson Energy Infrastructure Fund
KYN
$2.49B
$4.13K ﹤0.01%
400
-5,000
-93% -$49.4K
DEI icon
2090
Douglas Emmett
DEI
$1.92B
$4.13K ﹤0.01%
310
SIG icon
2091
Signet Jewelers
SIG
$3.65B
$4.12K ﹤0.01%
46
+14
+44% +$1.38K
MFIC icon
2092
MidCap Financial Investment
MFIC
$805M
$4.1K ﹤0.01%
271
IRWD icon
2093
Ironwood Pharmaceuticals
IRWD
$692M
$4.09K ﹤0.01%
627
-339
-35% -$2.4K
AORT icon
2094
Artivion
AORT
$1.34B
$4.08K ﹤0.01%
159
YEXT icon
2095
Yext
YEXT
$573M
$4.08K ﹤0.01%
762
+101
+15% +$544
KROS icon
2096
Keros Therapeutics
KROS
$210M
$4.07K ﹤0.01%
89
NHI icon
2097
National Health Investors
NHI
$3.4B
$4.06K ﹤0.01%
60
SSTK icon
2098
Shutterstock
SSTK
$205M
$4.03K ﹤0.01%
104
-182
-64% -$7.4K
MAIN icon
2099
Main Street Capital
MAIN
$5.49B
$4.02K ﹤0.01%
80
SRI icon
2100
Stoneridge
SRI
$196M
$3.99K ﹤0.01%
250
+35
+16% +$560

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.